Mubasher TV
Contact Us Advertising   العربية

Sector News

Photo Archive
30 July 01:15 PM SPIMACO enters into cross-border distribution agreements
Riyadh — Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) has signed distribution agreements on 29 July 2026 with subsidiaries of Cigalah Medical Company, according to a bourse filing. The contracts appoint …
Jamjoom Pharma
30 July 05:45 AM Jamjoom Pharma inks exclusive deal with Switzerland’s Idorsia
Riyadh - Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) has signed an exclusive agreement with Idorsia Limited for the distribution and commercialization of QUVIVIQ™ (daridorexant) in Saudi Arabia and the Levant region, …
Photo Archive
30 July 05:38 AM SPIMACO generates 110% higher net profits in Q2-26
Riyadh – Mubasher: The net profits of Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) surged by 109.82% for the second quarter (Q2) of 2026, reaching SAR 68.40 million. The quarterly results were compared to SAR 32.60 …
Saudi Exchange (Tadawul)
23 July 05:03 PM Tadawul registers SAR 166m in total negotiated deals on 23 July
Riyadh – Mubasher: The Saudi Exchange (Tadawul) recorded 13 negotiated deals carried out on five listed entities during the 23 July 2026 session. The implemented transactions held a combined value of SAR 166.04 million through a total of 5.67 …
Photo Archive
23 July 02:48 PM Jamjoom Pharma witnesses negotiated deal of SAR 3.5m
Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) recorded a negotiated transaction valued at SAR 3.52 million during the 23 July 2026 session on the Saudi market. The deal, which was carried out at 12:07, comprised …
Photo Archive
23 July 12:09 PM Jamjoom Pharma seals binding agreement with PIF-owned Lifera
Riyadh - Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) has signed a binding share subscription agreement and a shareholders’ agreement with Lifera, a commercial-scale biopharmaceutical company owned by the Public Investment …
Photo Archive
22 July 04:38 PM Jamjoom Pharma unveils SAR 154m interim dividends for H1-26
Riyadh - Mubasher: The board of Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) has approved the distribution of SAR 154 million in interim cash dividends to shareholders for the first half (H1) of 2026. The total payout is based on 70 …
Photo Archive
22 July 11:17 AM Jamjoom Pharma’s net profits up to SAR 306m in H1-26
Riyadh - Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) generated a net profit of SAR 137.63 million for the second quarter (Q2) of 2026, a 4.25% increase from SAR 132.02 million in the prior-year period. The pharmaceutical …
Saudi Exchange  (Tadawul)
21 July 08:10 PM Tadawul records 5 negotiated deals exceeding SAR 340.5m on July 21
Riyadh – Mubasher: The Saudi Exchange (Tadawul) witnessed the execution of five negotiated deals on Tuesday, 21 July 2026, at a combined value of SAR 340.54 million. The transactions involved a combined volume of 12.46 million shares across four …
Photo Archive
21 July 07:57 PM Two negotiated deals worth over SAR 326m executed on SPIMACO
Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) registered an additional negotiated deal during the 21 July 2026 session on the Saudi market at 15:46. The transaction was valued at SAR 163.17 …
Photo Archive
21 July 07:44 PM SPIMACO witnesses negotiated deal on nearly 6m shares
Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) saw a negotiated deal amounting to SAR 163.17 million executed during the 21 July 2026 session on the Saudi market at 15:45. The transaction was …
Arab Company for Drug Industries and Medical Appliances (ACDIMA)
21 July 06:20 PM Pan-Arab shareholding firm ACDIMA divests nearly 100% stake in SPIMACO for SAR 326m
Riyadh – Mubasher: GIB Capital, acting in its capacity as the financial advisor to the Arab Company for Drug Industries and Medical Appliances, commonly known as ACDIMA, has announced the successful completion of a significant share sale in the …
Photo Archive
9 July 10:38 PM SPIMACO records SAR 87m transaction on Tadawul
Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) recorded a special deal executed on the Saudi Exchange (Tadawul) on 9 July 2026. The transaction was implemented on 3.12 million shares at SAR 27.80 …
Photo Archive
7 July 03:52 PM SPIMACO corrects Q1-26 EPS figure
Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) issued a corrective disclosure regarding its preliminary financial results for the three-month period ended 31 March 2026. The amendment follows an …
Photo Archive
14 June 06:07 PM SPIMACO ups equity ownership in MENA-focused ENAYAH to 63%
Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) has entered into a binding agreement to raise its stake in Arabian Medical Products Manufacturing Company (ENAYAH). SPIMACO intends to buy an …
Photo Archive
14 June 10:25 AM SPIMACO raises facility deal with SNB to SAR 350m
Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) penned an agreement to renew and increase Sharia-compliant credit facilities with the Saudi National Bank (SNB) on 11 June 2026. The short-term …
Photo Archive
10 June 02:44 PM SPIMACO to pay SAR 42m cash dividends for 2025
Riyadh – Mubasher: The shareholders of Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) approved the board’s proposal to pay cash dividends of SAR 42 million for 2025. The cash dividends account for 3.50% of the …
Photo Gallery
8 June 11:25 AM Jamjoom Pharma pens MoU to boost healthcare services in Saudi Arabia
Riyadh - Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) inked a memorandum of understanding (MoU) with the General Administration of Pharmaceutical Care at the Ministry of Health Saudi Arabia, according to a press release. The …
Photo Archive
4 May 09:38 AM SPIMACO’s profits exceed SAR 65m in Q1-26 initial results
Riyadh – Mubasher: The net profits attributable to the owners of Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) amounted to SAR 65.10 million in the first quarter (Q1) of 2026. The quarterly profits were lower by …
Photo Archive
26 April 10:45 AM Jamjoom Pharma logs 7% higher net profits in Q1-26
Riyadh - Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) registered an annual increase of 7.11% in net profits to SAR 168.21 million during the first quarter (Q1) of 2026, compared with SAR 157.03 million. The earnings per share …
Photo Archive
16 April 07:02 PM Avalon Pharma appoints new leadership team
Riyadh - Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) named Ahmad Shaher Al Tabbaa as the board’s Chairman for the next four years. The ordinary general meeting (OGM), which was held on 9 April 2026, also resolved to …
Photo Archive
6 April 06:07 PM CMA greenlights Avalon Pharma’s capital hike
Riyadh - Mubasher: The Capital Market Authority (CMA) approved the request of Middle East Pharmaceutical Industries Company (Avalon Pharma) to increase its capital to SAR 350 million from SAR 200 million. The company will issue three bonus shares …
Photo Archive
1 April 10:14 PM SPIMACO achieves 653% profit growth in 2025 amid SAR 1.7bn revenue; dividends unveiled
Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) registered a jump of 652.65% in net profit to SAR 184.40 million in 2025 from SAR 24.50 million in 2024, according to the income statements. The …
Photo Archive
24 February 12:20 PM Jamjoom Pharma’s profits surge 30% in 2025; dividends for H2 unveiled
Riyadh - Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) recorded 30.10% year-on-year (YoY) higher net profits attributable to the shareholders at SAR 463.80 million in 2025, compared with SAR 356.50 million. The earnings per …
Photo Archive
4 February 11:16 AM Avalon Pharma, Bio-Thera reach license agreements for BAT3306 in MENA
Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) entered into a strategic commercialization agreement with Bio-Thera Solutions to register Pembrolizumab in Saudi Arabia and MENA markets Under the agreement, …